The combination of automation and digitalization in the university and industrial research landscape catalyse innovations and at the same time society.
We herein describe the development and application of a modular technology platform which incorporates recent advances in plate-based microscale chemistry, automated purification, in situ quantification, and robotic liquid handling to enable rapid access to high-quality chemical matter already formatted for assays.
BASEL, Switzerland – [March 7, 2024]: Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions.
The field of C-H functionalization chemistry has experienced rapid growth in the past twenty years, with increasingly powerful applications in organic synthesis.
The implementation of a dialysis method for the simultaneous purification of different polymer materials in a commercially available automated parallel synthesizer (APS) is discussed.
The aim of the current study was (1) to develop an automation-based protocol for in vitro assessment of enzymatic drug stability at fasted- and fed-state intestinal conditions, (2) to characterize the inter-individual variability of drug degradation in fasted- and fed-state human intestinal fluids, and (3) to compare the obtained in vitro results to drug degradation in human intestinal fluids by taking variability into account.
We are thrilled to share some exciting news about a significant development at Chemspeed - we are joining forces with BRUKER, a NASDAQ listed company!
Wir haben aufregende Neuigkeiten zu teilen: Chemspeed schließt sich mit BRUKER zusammen, einem Unternehmen, das an der NASDAQ gelistet ist!
A small, low-cost, self-produced photometer is implemented into a synthesis robot and combined with a modified UV chamber to enable automated sampling and online characterization.